Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 11INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 2Head & Neck 1Breast 1

Conditions

Neoplasms 1Lymphedema 1Head and Neck Neoplasms 1

Interventions

pembrolizumab 166Cisplatin 112Cetuximab 76Nivolumab 52Carboplatin 51Fluorouracil 48Paclitaxel 42Docetaxel 37Gemcitabine 30Radiotherapy 28Capecitabine 19Cyclophosphamide 18durvalumab 17Injections 17lenvatinib 16atezolizumab 16cemiplimab 15spartalizumab 13fludarabine 13avelumab 12Ipilimumab 12Pemetrexed 11130-nm albumin-bound paclitaxel 11Oxaliplatin 10Gefitinib 10tremelimumab 9Drug Therapy 9tislelizumab 8epacadostat 8budigalimab 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Indocyanine Green × Head & Neck × Clear all
NCT02946021 2019-04-09

Response to Intermittent Pneumatic Compression Therapy in Head and Neck Cancer-Related Lymphedema

Tactile Medical

Phase 1/2 Completed
11 enrolled 6 charts
Head & Neck

Head and Neck Neoplasms, Lymphedema, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡